181 related articles for article (PubMed ID: 37773553)
1. Dysregulated ceramides metabolism via PTPN11 exposes a metabolic vulnerability to breast cancer metastasis.
Qiao S; Wang T; Wang H
Med Oncol; 2023 Sep; 40(11):310. PubMed ID: 37773553
[TBL] [Abstract][Full Text] [Related]
2. A pan-cancer analysis confirms PTPN11's potential as a prognostic and immunological biomarker.
Cao Y; Duan H; Su A; Xu L; Lai B
Aging (Albany NY); 2022 Jul; 14(13):5590-5610. PubMed ID: 35802774
[TBL] [Abstract][Full Text] [Related]
3. Identification of protein tyrosine phosphatases and dual-specificity phosphatases in mammalian spermatozoa and their role in sperm motility and protein tyrosine phosphorylation.
González-Fernández L; Ortega-Ferrusola C; Macias-Garcia B; Salido GM; Peña FJ; Tapia JA
Biol Reprod; 2009 Jun; 80(6):1239-52. PubMed ID: 19211810
[TBL] [Abstract][Full Text] [Related]
4. Role of protein phosphatases in the cancer microenvironment.
Ruvolo PP
Biochim Biophys Acta Mol Cell Res; 2019 Jan; 1866(1):144-152. PubMed ID: 30026077
[TBL] [Abstract][Full Text] [Related]
5. Protein tyrosine phosphatases as novel targets in breast cancer therapy.
Nunes-Xavier CE; Martín-Pérez J; Elson A; Pulido R
Biochim Biophys Acta; 2013 Dec; 1836(2):211-26. PubMed ID: 23756181
[TBL] [Abstract][Full Text] [Related]
6. Identification of chebulinic acid as a dual targeting inhibitor of protein tyrosine phosphatases relevant to insulin resistance.
Yoon SY; Kang HJ; Ahn D; Hwang JY; Kwon SJ; Chung SJ
Bioorg Chem; 2019 Sep; 90():103087. PubMed ID: 31284101
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of protein phosphatase non-receptor type 11 (PTPN11) in gastric carcinomas.
Kim JS; Shin OR; Kim HK; Cho YS; An CH; Lim KW; Kim SS
Dig Dis Sci; 2010 Jun; 55(6):1565-9. PubMed ID: 19690960
[TBL] [Abstract][Full Text] [Related]
8. The tyrosine phosphatase Shp2 (PTPN11) in cancer.
Chan G; Kalaitzidis D; Neel BG
Cancer Metastasis Rev; 2008 Jun; 27(2):179-92. PubMed ID: 18286234
[TBL] [Abstract][Full Text] [Related]
9. Expression profile of tyrosine phosphatases in HER2 breast cancer cells and tumors.
Lucci MA; Orlandi R; Triulzi T; Tagliabue E; Balsari A; Villa-Moruzzi E
Cell Oncol; 2010; 32(5-6):361-72. PubMed ID: 20413845
[TBL] [Abstract][Full Text] [Related]
10. Induction of a tumor-associated activating mutation in protein tyrosine phosphatase Ptpn11 (Shp2) enhances mitochondrial metabolism, leading to oxidative stress and senescence.
Zheng H; Li S; Hsu P; Qu CK
J Biol Chem; 2013 Sep; 288(36):25727-25738. PubMed ID: 23884424
[TBL] [Abstract][Full Text] [Related]
11.
Hill KS; Roberts ER; Wang X; Marin E; Park TD; Son S; Ren Y; Fang B; Yoder S; Kim S; Wan L; Sarnaik AA; Koomen JM; Messina JL; Teer JK; Kim Y; Wu J; Chalfant CE; Kim M
Mol Cancer Res; 2019 Feb; 17(2):583-593. PubMed ID: 30355677
[TBL] [Abstract][Full Text] [Related]
12. [The Biological Function of SHP2 in Human Disease].
Li SM
Mol Biol (Mosk); 2016; 50(1):27-33. PubMed ID: 27028808
[TBL] [Abstract][Full Text] [Related]
13. Nepetin Acts as a Multi-Targeting Inhibitor of Protein Tyrosine Phosphatases Relevant to Insulin Resistance.
Yoon SY; Ahn D; Kim JK; Seo SO; Chung SJ
Chem Biodivers; 2022 Jan; 19(1):e202100600. PubMed ID: 34725898
[TBL] [Abstract][Full Text] [Related]
14. Protein tyrosine phosphatome metabolic screen identifies TC-PTP as a positive regulator of cancer cell bioenergetics and mitochondrial dynamics.
Vinette V; Aubry I; Insull H; Uetani N; Hardy S; Tremblay ML
FASEB J; 2021 Jul; 35(7):e21708. PubMed ID: 34169549
[TBL] [Abstract][Full Text] [Related]
15. Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemia.
Jenkins C; Luty SB; Maxson JE; Eide CA; Abel ML; Togiai C; Nemecek ER; Bottomly D; McWeeney SK; Wilmot B; Loriaux M; Chang BH; Tyner JW
Sci Signal; 2018 Jul; 11(539):. PubMed ID: 30018082
[TBL] [Abstract][Full Text] [Related]
16. The expression patterns and the diagnostic/prognostic roles of PTPN family members in digestive tract cancers.
Chen J; Zhao X; Yuan Y; Jing JJ
Cancer Cell Int; 2020; 20():238. PubMed ID: 32536826
[TBL] [Abstract][Full Text] [Related]
17. Nuclear import of PTPN18 inhibits breast cancer metastasis mediated by MVP and importin β2.
Wang T; Ba X; Zhang X; Zhang N; Wang G; Bai B; Li T; Zhao J; Zhao Y; Yu Y; Wang B
Cell Death Dis; 2022 Aug; 13(8):720. PubMed ID: 35982039
[TBL] [Abstract][Full Text] [Related]
18. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
Bentires-Alj M; Paez JG; David FS; Keilhack H; Halmos B; Naoki K; Maris JM; Richardson A; Bardelli A; Sugarbaker DJ; Richards WG; Du J; Girard L; Minna JD; Loh ML; Fisher DE; Velculescu VE; Vogelstein B; Meyerson M; Sellers WR; Neel BG
Cancer Res; 2004 Dec; 64(24):8816-20. PubMed ID: 15604238
[TBL] [Abstract][Full Text] [Related]
19. Protein Tyrosine Phosphatase Non-Receptor 11 (
Richards CE; Elamin YY; Carr A; Gately K; Rafee S; Cremona M; Hanrahan E; Smyth R; Ryan D; Morgan RK; Kennedy S; Hudson L; Fay J; O'Byrne K; Hennessy BT; Toomey S
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445722
[No Abstract] [Full Text] [Related]
20. Discovery of novel furanylbenzamide inhibitors that target oncogenic tyrosine phosphatase SHP2 in leukemia cells.
Raveendra-Panickar D; Finlay D; Layng FI; Lambert LJ; Celeridad M; Zhao M; Barbosa K; De Backer LJS; Kwong E; Gosalia P; Rodiles S; Holleran J; Ardecky R; Grotegut S; Olson S; Hutchinson JH; Pasquale EB; Vuori K; Deshpande AJ; Cosford NDP; Tautz L
J Biol Chem; 2022 Jan; 298(1):101477. PubMed ID: 34896393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
